Vericel to Participate in Multiple Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced participation in multiple upcoming investor conferences.

• Nick Colangelo, president and CEO and Gerard Michel, CFO and VP of Corporate Development will be attending the  BTIG Annual Healthcare Conference in Snowbird, UT on Wednesday, February 27, 2019 
• Nick Colangelo, president and CEO will present the latest company overview at the 8th Annual Leerink Partners Annual Global Healthcare Conference in New York, NY on Friday, March, 1 2019 at 10:00AM ET with live webcast at http://wsw.com/webcast/leerink32/vcel/

The presentation may also be accessed from the news and events section of the Vericel website.

About Vericel CorporationVericel is a leader in advanced cell therapies for the sports medicine and severe burn care markets.  The company markets two cell therapy products in the United States.  MACI® (autologous cultured chondrocytes on porcine collagen membrane) is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults.  Epicel® (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area.  For more information, please visit the company's website at www.vcel.com.

Epicel® and MACI® are registered trademarks of Vericel Corporation. © 2019 Vericel Corporation. All rights reserved.

Global Media Contacts:David SchullRusso Partners LLC[email protected]+1 212-845-4271 (office)+1 858-717-2310 (mobile)

Karen ChaseRusso Partners LLC[email protected]+1 646-942-5627 (office)+1 917-547-0434 (mobile)

Investor Contacts:Chad RubinSolebury Trout[email protected]+1 (646) 378-2947

Lee SternSolebury Trout[email protected]+1 (646) 378-2922

You May Also Be Interested In

• After Sacrificing Summer, Financial Threats Continue for Consumers in Debt
• Cherry Bekaert's Mid-year PE Report: Sponsors Deploy $461 Billion While Shifting Toward Smaller Deals
• Talkdesk named a Leader in two 2026 IDC MarketScape Vendor Assessments